BioSpace News Archive

Novocure, a global oncology company striving to extend survival in some of the most aggressive forms of cancer, announced the pricing of $500 million aggregate principal amount of its 0% Convertible Senior Notes due 2025 through a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

Alveo Technologies, today announced it has been awarded a grant to improve upon the performance and usability of its testing platform, and if successful, to advance the development and scale manufacturing of the company’s be.well™ COVID-19 test from the Bill & Melinda Gates Foundation.

Aurora Spine Corporation, a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announced it has commercially launched its proprietary SOLOTM ALIF Stand-Alone Cage system to its innovative suite of MIS products used in spinal surgery.